AIDX - 20/20 Biolabs, Inc. Common Stock

20/20 Biolabs, Inc. (AIDX)

NCM · Common · CUSIP 90138K101

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for AIDX and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 90138K101

Links: Home Page Investor Relations News

Business: 20/20 BioLabs develops and commercializes, AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.

Company Contact

CEO: Jonathan Cohen
CFO: Alan B. Bergman
Headquarters: 15810 Gaither Road, Suite 235, Gaithersburg, MD 20877
Phone: 240-453-6339
Investor Relations: Chris Tyson, MZ Group · 949-491-8235 · AIDX@mzgroup.us
SEC EDGAR Filings: View filings »